QuantomiX Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

QuantomiX Ltd. - overview

Established

2001

Location

Rehovot, -, Israel

Primary Industry

Biotechnology

About

QuantomiX Ltd. focuses on providing premium domain name offerings to businesses aiming to establish a robust online presence. The company emphasizes high-value digital identities that enhance brand credibility. QuantomiX Ltd.


specializes in premium domain names, having been founded in 2001 in Rehovot, Israel. The company has engaged in four deals with its most recent acquisition being El-Mul Technologies in November 2007. The latest funding round was Series B, during which the company raised USD 5. 000 mn from investors including Evergreen Partners, Pitango Venture Capital, and SCP Vitalife Partners.


QuantomiX. com specializes in premium domain name offerings that cater to businesses seeking to establish a strong online identity. The core services revolve around the sale of premium domain names, with a particular emphasis on the domain Quantomix. com, which is currently listed for sale at USD 25,100.


These domain names serve as critical assets for businesses aiming to build trust and credibility with their customers, enhancing their digital presence in a competitive marketplace. The company targets a diverse range of industries, including technology, e-commerce, and branding, with clients spanning various geographical markets including North America, Europe, and Asia. The end users of these services are primarily companies and entrepreneurs looking for high-value domain identities that can appreciate over time, solidifying their brand image on the Internet. QuantomiX.


com generates revenue primarily through direct sales of its premium domain names. The transaction structure is straightforward, involving direct purchase agreements where clients pay a fixed price for the domain name, as exemplified by the listing price of Quantomix. com. Revenue is derived from individual transactions that take place in a B2B context, where businesses engage directly with QuantomiX.


com to acquire domain names that align with their branding strategies. The pricing model is based on the premium nature of the domain names, reflecting their potential for appreciation and market demand. Each transaction is typically completed through a secure payment process, ensuring a seamless experience for clients investing in their online identities. Looking ahead, QuantomiX Ltd.


plans to expand its offerings by developing additional premium domain names that cater to emerging online markets. The company is focusing on expanding into specific regions such as Asia and Europe by the end of 2024. The recent Series B funding will be utilized to support these initiatives and enhance the company’s marketing efforts to reach new clients. The acquisition of El-Mul Technologies in November 2007 is expected to create synergies that will further bolster QuantomiX's growth in the premium domain market.


Current Investors

Pitango, SCP Vitalife Partners, Shrem, Fudim, Kelner Technologies Ltd

Primary Industry

Biotechnology

Sub Industries

Biotechnology

Website

www.quantomix.com

Company Stage

Acquired

Total Amount Raised

Subscriber access only

QuantomiX Ltd. - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

QuantomiX Ltd. - key contacts

NamePositionStart DateEnd DateVcardBio 
Board Member and InvestorBM

BM Board Member

Want to see more?

Request a demo for full access to this profile

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.